Regeneron's antibody drug shows protection against COVID-19
Regeneron Pharmaceuticals Inc said on Monday a single dose of its antibody cocktail reduced the risk of contracting COVID-19 by 81.6% in a late-stage trial, in the two to eight months period following the drug's administration.
影片文字轉錄稿
[MUSIC PLAYING]